Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US2561352038

SecurityRDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership2,541,889 shares
Latest Disclosed Value $ 35,688,122
Alliancebernstein L.p. reports 8,383.99% increase in ownership of RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 2,541,889 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) (US:RDY) valued at $35,205,163 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 29,961 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock). This represents a change in shares of 8,383.99% during the quarter. The current value of the position is $33,654,610 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F DR REDDYS LABS ADR 256135203 2,541,889 2,511,928 8,383.99 35,688 8,397.14 0.0116
2026-02-17 2025-12-31 13F DR REDDYS LABS ADR 256135203 29,961 14,011 87.84 421 89.19 0.0001
2025-11-14 2025-09-30 13F DR REDDYS LABS ADR 256135203 15,950 440 2.84 223 -4.72 0.0001
2025-08-14 2025-06-30 13F DR REDDYS LABS ADR 256135203 15,510 15,510 233 0.0001
2024-02-14 2023-12-31 13F DR REDDYS LABS ADR 256135203 0 -19,702 -100.00 0 -100.00
2023-11-14 2023-09-30 13F DR REDDYS LABS ADR 256135203 19,702 2,674 15.70 1,317 22.63 0.0006
2023-08-15 2023-06-30 13F DR REDDYS LABS ADR 256135203 17,028 4,018 30.88 1,075 45.14 0.0004
2023-05-15 2023-03-31 13F DR REDDYS LABS ADR 256135203 13,010 13,010 741 0.0003
2021-02-08 2020-12-31 13F DR REDDYS LABS ADR 256135203 0 -10,109 -100.00 0 -100.00
2020-11-12 2020-09-30 13F DR REDDYS LABS ADR 256135203 10,109 0 0.00 703 31.16 0.0004
2020-08-13 2020-06-30 13F DR REDDYS LABS ADR 256135203 10,109 -441 -4.18 536 26.12 0.0003
2020-05-14 2020-03-31 13F DR REDDYS LABS ADR 256135203 10,550 0 0.00 425 -0.70 0.0003
2020-02-18 2019-12-31 13F DR REDDYS LABS ADR 256135203 10,550 -360 -3.30 428 3.63 0.0002
2019-11-14 2019-09-30 13F DR REDDYS LABS ADR 256135203 10,910 -260 -2.33 413 -1.43 0.0003
2019-08-14 2019-06-30 13F DR REDDYS LABS ADR 256135203 11,170 1,867 20.07 419 11.14 0.0003
2019-05-14 2019-03-31 13F DR REDDYS LABS ADR 256135203 9,303 0 0.00 377 7.41 0.0002
2019-02-13 2018-12-31 13F DR REDDYS LABS ADR 256135203 9,303 0 0.00 351 9.01 0.0003
2018-11-08 2018-09-30 13F DR REDDYS LABS ADR 256135203 9,303 -9,913 -51.59 322 -47.98 0.0002
2018-08-13 2018-06-30 13F DR REDDYS LABS ADR 256135203 19,216 0 0.00 619 -1.43 0.0004
2018-05-14 2018-03-31 13F DR REDDYS LABS ADR 256135203 19,216 -700 -3.51 628 -16.04 0.0005
2018-02-13 2017-12-31 13F DR REDDYS LABS ADR 256135203 19,916 -170 -0.85 748 4.32 0.0005
2017-11-13 2017-09-30 13F DR REDDYS LABS ADR 256135203 20,086 11,001 121.09 717 87.21 0.0005
2017-08-10 2017-06-30 13F DR REDDYS LABS ADR 256135203 9,085 1,277 16.36 383 22.36 0.0003
2017-05-11 2017-03-31 13F DR REDDYS LABS ADR 256135203 7,808 2,787 55.51 313 37.89 0.0002
2017-02-13 2016-12-31 13F DR REDDYS LABS ADR 256135203 5,021 5,021 0.00 227 0.0002
2016-11-10 2016-09-30 13F DR REDDYS LABS ADR 256135203 0 -48,611 -100.00 0 -100.00
2016-08-11 2016-06-30 13F DR REDDYS LABS ADR 256135203 48,611 111 0.23 2,490 13.59 0.0021
2016-05-13 2016-03-31 13F DR REDDYS LABS ADR 256135203 48,500 140 0.29 2,192 -2.10 0.0019
2016-02-16 2015-12-31 13F/A-1 DR REDDYS LABS ADR 256135203 48,360 9,180 23.43 2,239 -10.58 0.0019
2016-02-12 2015-12-31 13F DR REDDYS LABS ADR 256135203 48,360 3,091
2015-11-13 2015-09-30 13F DR REDDYS LABS ADR 256135203 39,180 39,180 0.00 2,504 0.0021
2015-02-13 2014-12-31 13F DR REDDY'S LABORATORIES ADR 256135203 0 -6,930 -100.00 0 -100.00
2014-11-13 2014-09-30 13F DR REDDY'S LABORATORIES ADR 256135203 6,930 1,060 18.06 364 43.87 0.0003
2014-08-13 2014-06-30 13F DR REDDY'S LABORATORIES ADR 256135203 5,870 -440 -6.97 253 -8.66 0.0002
2014-05-13 2014-03-31 13F DR REDDY'S LABORATORIES ADR 256135203 6,310 2,620 71.00 277 83.44 0.0002
2014-02-13 2013-12-31 13F DR REDDY'S LABORATORIES ADR 256135203 3,690 0 0.00 151 8.63 0.0001
2013-11-14 2013-09-30 13F DR REDDY'S LABORATORIES ADR 256135203 3,690 3,250 738.64 139 717.65 0.0001
2013-08-13 2013-06-30 13F DR REDDY'S LABORATORIES ADR 256135203 440 440 17 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.